novo nordisk ozempic - Search News

Ozempic, chronic kidney disease and Novo Nordisk

Reuters on MSN · 20h

US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD),

Bloomberg on MSN · 11h

Novo’s Ozempic Gains US Nod for Kidney Disease, Widening Use

Novo Nordisk A/S’s blockbuster Ozempic won US approval to treat chronic kidney disease in patients who also have type 2 diabetes, further expanding the popular drug’s use.

Medscape · 35m

Ozempic Receives New Indications in Chronic Kidney Disease

Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with chronic kidney disease.

With Wegovy, Ozempic on the Line, Novo Asks Court to Speed Up IRA Complaint

The U.S. Centers for Medicare and Medicaid Services has named Novo Nordisk’s Wegovy, Ozempic and Rybelsus as part of the ...

1d

Ozempic Defendants Seek to Shave 'Tacked On' Claims From MDL Complaint

Novo Nordisk and Eli Lilly's motion to dismiss took aim at most of the counts asserted in the plaintiffs’ master long-form ...

2don MSN

Ozempic maker Novo Nordisk will cap insulin prices to settle a lawsuit

This story incorporates reporting fromdevdiscourse, WJON and KIMT.Novo Nordisk has settled a lawsuit with Minnesota, agreeing ...

Outsourcing-pharma1d

Novo Nordisk’s next-generation obesity drug shows promise in early clinical trials

Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results